____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Explore our range of useful resources designed to support you and your SPMS patients.
You can access materials and educational webinars that will provide you with more in-depth information about MAYZENT, and support you in the day-to-day management of patients receiving MAYZENT. You can download some of the patient materials to share with your patients.
If you would like to receive printed copies of any of these materials, please contact your local MAYZENT key account manager.
Indication: MAYZENT is indicated for the treatment of adult patients with SPMS with active disease evidenced by relapses or imaging features of inflammatory activity.1
SPMS, secondary progressive multiple sclerosis.
Reference:
- MAYZENT (siponimod) Summary of Product Characteristics.